Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
As of close of business last night, Tonix Pharmaceuticals Holding Corp’s stock clocked out at $15.36, up 0.92% from its previous closing price of $15.22. In other words, the price has increased by $0.92 from its previous closing price. On the day, 0.53 million shares were traded. TNXP stock price reached its highest trading level at $15.5 during the session, while it also had its lowest trading level at $14.95.
Ratios:
To gain a deeper understanding of TNXP’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.62 and its Current Ratio is at 9.89. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On April 18, 2019, ROTH Capital Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $4.
ROTH Capital Upgraded its Neutral to Buy on August 18, 2017, while the target price for the stock was maintained at $6.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 21 ’25 when Taylor Carolyn E. bought 418 shares for $36.03 per share. The transaction valued at 15,061 led to the insider holds 418 shares of the business.
Treco James bought 250 shares of TNXP for $9,000 on Aug 20 ’25. The Director now owns 250 shares after completing the transaction at $36.00 per share. On May 15 ’25, another insider, LEDERMAN SETH, who serves as the Chief Executive Officer of the company, bought 4,000 shares for $21.55 each. As a result, the insider paid 86,200 and bolstered with 4,005 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TNXP now has a Market Capitalization of 196424752 and an Enterprise Value of -8742315. For the stock, the TTM Price-to-Sale (P/S) ratio is 19.07 while its Price-to-Book (P/B) ratio in mrq is 0.68. Its current Enterprise Value per Revenue stands at -0.849 whereas that against EBITDA is 0.09.
Stock Price History:
The Beta on a monthly basis for TNXP is 1.90, which has changed by -0.4146154 over the last 52 weeks, in comparison to a change of 0.16623151 over the same period for the S&P500. Over the past 52 weeks, TNXP has reached a high of $69.97, while it has fallen to a 52-week low of $6.76. The 50-Day Moving Average of the stock is -11.40%, while the 200-Day Moving Average is calculated to be -43.15%.
Shares Statistics:
It appears that TNXP traded 718.85K shares on average per day over the past three months and 597170 shares per day over the past ten days. A total of 12.79M shares are outstanding, with a floating share count of 12.78M. Insiders hold about 0.04% of the company’s shares, while institutions hold 23.33% stake in the company. Shares short for TNXP as of 1765756800 were 2216942 with a Short Ratio of 3.08, compared to 1763078400 on 1944721. Therefore, it implies a Short% of Shares Outstanding of 2216942 and a Short% of Float of 18.83.
